Hospitalization for COVID-19 in patients treated with selected immunosuppressant and immunomodulating agents, compared to the general population: A Danish cohort study.

Bente Mertz NørgårdJan NielsenTorben KnudsenRasmus Gaardskaer NielsenMichael Due LarsenLine Riis JølvingJens Kjeldsen

Published in: British journal of clinical pharmacology (2020)

Patients treated with systemic corticosteroids and cyclosporine/tacrolimus had a significantly increased risk of being hospitalized for COVID-19. Our study does not uncover whether the increased risk is related to the drug itself, the underlying condition for which the patient is treated or other factors.

Keyphrases

coronavirus disease
sars cov
case report
respiratory syndrome coronavirus
emergency department
drug induced
newly diagnosed